The Proposed Transaction is planned to be completed by way of a three-cornered merger pursuant to which, a wholly owned subsidiary of the Company incorporated in Nevada will merge with 3Win and 3Win ...
The company expects to submit the new 510 (k) application in the coming quarter and will provide updates on its progress in the regulatory process, as appropriate.
OTTAWA, Ontario, Sept. 28, 2024 (GLOBE NEWSWIRE) -- As the world observes International Safe Abortion Day, the Society of Obstetricians and Gynaecologists of Canada (SOGC) is reaffirming its ...
Ce n’est pas la première mise en garde sur les effets cognitifs négatifs du tabac. Cette recherche menée à l’University College London (UCL) nous explique pourquoi le tabagisme est un facteur majeur ...
LA JOLLA, CA, Sept. 25, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio,” “we,” “our,” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T ...
Vancouver, B.C., Toronto, ON, Sept. 25, 2024 (GLOBE NEWSWIRE) -- On September 30, LifeLabs will pause operations to recognize National Day for Truth and Reconciliation and Orange Shirt Day. This day ...
HAMPTON, N.J., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today new data demonstrating sustained and deepening disease efficacy and a well tolerated safety ...
IRVING, Texas, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Dallas Business Journal has selected U.S. Oral Surgery Management (USOSM) Chief Operations Officer Alisa Ulrey as a 2024 C-Suite Leaders Awards ...
Inauguration of Angelika Amon research building in Vienna Sustainable research building at a cost of EUR 60 million offers modern office and laboratory space Over the past five years, Boehringer’s ...
Selon l’Organisation mondiale de la santé (OMS), plus de 700.000 personnes se suicident chaque année. Pouvoir détecter le risque de suicide reste un défi, et de nombreuses équipes travaillent sur des ...
Acquisition drives Sanner Group’s mission to offer a suite of world leading development and manufacturing services for its customers across the drug delivery and medical device sectors 25 September ...
Résultats cliniques attendus avant la fin de l’année 2024, issus des données cliniques compassionnelles mises à jour et de l’étude pilote PhagoDAIR Demandes d’autorisation d’essai clinique (IND aux ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback